Kezar Life Sciences, Inc.
KZR
|
NASDAQ
|
0 Urmăritori
Company Quality
Profitability Score
9/100
Solvency Score
50/100
Dividends
Dividends data currently unavailable.Earnings
8/11/2025
in 50 days
-
Revenue est.
-2.65
EPS est.
My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sector
Biotechnology
Industrie
Dr. Christopher J. Kirk Ph.D.
CEO
55
Angajați
South San Francisco
Sediu
US
Țară
Key Metrics TTM
Valuation
Market cap.
$33MEnterprise Value
$6.3MPrice to Earnings
-0.42Price to Sales
0.00Price to Book
0.32Price to Cash Flow
-0.48Profitability
Return on Assets
-62.78%Return on Equity
-62.32%Return on Invested Capital
-72.13%Gross Margin
0.00%Operating Margin
0.00%Net Margin
0.00%Liquidity
Quick Ratio
7.09Current Ratio
7.09Cash Ratio
2.18Inventory Turnover
0.00Asset Turnover
0.00Total Liabilities
$22MSolvency
Debt to Assets
0.08Debt to Equity
N/AInterest Coverage
-54.89Equity Ratio
0.82Long-term Debt to Cap.
0.01Altman Z-Score
-5.22Performance
Earnings Waterfall
Debt level and coverage
Earnings
Feed
There are no posts to show right now.